How were Apollo Endosurgery's earnings last quarter?

Apollo Endosurgery, Inc. (NASDAQ:APEN) posted its quarterly earnings data on Sunday, October, 31st. The biotechnology company reported ($0.23) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.28) by $0.05. The biotechnology company had revenue of $16.35 million for the quarter, compared to the consensus estimate of $16.20 million. Apollo Endosurgery had a negative net margin of 51.84% and a negative trailing twelve-month return on equity of 89.48%. During the same period last year, the firm posted ($0.11) earnings per share.

What other stocks do shareholders of Apollo Endosurgery own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Apollo Endosurgery investors own include Obalon Therapeutics (OBLN) , Novavax (NVAX) , Inovio Pharmaceuticals (INO) , Onconova Therapeutics (ONTX) , OPKO Health (OPK) , Pfizer (PFE) , Sunesis Pharmaceuticals (SNSS) , Biocept (BIOC) , Co-Diagnostics (CODX) and Second Sight Medical Products (EYES) .

NASDAQ:APEN

Apollo Endosurgery (APEN) Stock Price, News & Analysis

→ Secret Bull Market Starts in This Unusual Sector (From Altimetry) (Ad)

Free APEN Stock Alerts

Notice: This company has been marked as potentially delisted and may not be actively trading.

Compare

Today's Range: N/A
50-Day Range: $9.87
▼
$10.00
52-Week Range: N/A

Volume: 1.66 million shs
Average Volume: 1.43 million shs
Market Capitalization: $579.72 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Stock Analysis

Get Apollo Endosurgery alerts:

Ad DTI

Biden’s $374B Giveaway Into This Sector

Biden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right here

Click here for the full story

About Apollo Endosurgery Stock (NASDAQ:APEN)

Apollo Endosurgery, Inc. is a medical technology company, which focuses on the design, development, and commercialization of medical devices to advance gastrointestinal therapeutic endoscopy. It offers Endoscopy, Surgical and Other products. The firm's endoscopy product portfolio consists of the OverStitch Endoscopic Suturing System, the OverStitch Sx Endoscopic Suturing System, and the Orbera Intragastric Balloon System. Its products are used by gastroenterologists and bariatric surgeons in a variety of settings to treat multiple gastrointestinal conditions including closure of acute perforations and chronic fistulas, inadvertent perforation of the GI tract, tissue closure after the removal of abnormal lesions in the esophagus, stomach or colon, the treatment of swallowing disorders, esophageal stent fixation, and obesity. The company was founded by Christopher J. Gostout and Dennis L. McWilliams in 2005 and is headquartered in Austin, TX.

Ad DTI

Biden’s $374B Giveaway Into This Sector

Biden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right here

Click here for the full story

APEN Stock News Headlines

February 1, 2024 | morningstar.com

Apollo Pipes Ltd 531761

November 12, 2023 | nypost.com

Astronaut Frank Borman, commander of the first Apollo mission to the moon, dead at 95

April 19, 2024 | DTI (Ad)

Biden’s $374B Giveaway Into This Sector

Biden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right here

November 5, 2023 | cnn.com

Apollo astronaut Ken Mattingly, who helped save the crew of Apollo 13, has died

May 10, 2023 | marketwatch.com

Gastric Band and Gastric Balloon Market to Witness Growth Acceleration | Apollo Endosurgery, Cousin Surgery, Spatz FGIA Inc

April 1, 2023 | finance.yahoo.com

Apollo Endosurgery Full Year 2022 Earnings: Revenues Beat Expectations, EPS Lags

March 29, 2023 | seekingalpha.com

APEN Apollo Endosurgery, Inc.

March 7, 2023 | finance.yahoo.com

Does This Valuation Of Apollo Endosurgery, Inc. (NASDAQ:APEN) Imply Investors Are Overpaying?

April 19, 2024 | DTI (Ad)

Biden’s $374B Giveaway Into This Sector

Biden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right here

February 2, 2023 | benzinga.com

SHAREHOLDER ALERT: Morris Kandinov Investigating ALBO, APEN, ATCX and PAYA Mergers and Acquisitions; Shareholders are Encouraged to Contact the Firm

January 11, 2023 | benzinga.com

SHAREHOLDER NOTICE: Brodsky & Smith Announces an Investigation of Apollo Endosurgery, Inc. (APEN)

December 15, 2022 | apnews.com

STOCKHOLDER ALERT: The M&A Class Action Firm Continues Investigating the Merger – SAL, VVNT, APEN, GRAY

December 13, 2022 | finance.yahoo.com

Apollo Endosurgery Announces Two Important Milestones in the Advancement of Endoscopic Procedures for Patients Living with Obesity

December 8, 2022 | msn.com

$1000 Invested In This Stock 5 Years Ago Would Be Worth $2,400 Today

December 5, 2022 | wsj.com

SHAREHOLDER ALERT: The M&A Class Action Firm Announces the Investigation of Apollo Endosurgery, Inc. - APEN

November 30, 2022 | bizjournals.com

Boston Scientific shells out $615M for gastro device firm

November 29, 2022 | nasdaq.com

Boston Scientific to buy Apollo Endosurgery for $417 million

November 29, 2022 | reuters.com

Boston Scientific to acquire Apollo Endosurgery in $615 mln deal

November 29, 2022 | finance.yahoo.com

Apollo Endosurgery to be Acquired by Boston Scientific

November 29, 2022 | finance.yahoo.com

Boston Scientific to acquire Apollo Endosurgery for $615 million in cash

November 21, 2022 | finance.yahoo.com

Apollo Endosurgery Completes Transition to European MDR Requirements for the OverStitch Systems, BIB and Orbera 365 intragastric balloons, and OverTube.

November 8, 2022 | finance.yahoo.com

Apollo Endosurgery, Inc. (NASDAQ:APEN) is largely controlled by institutional shareholders who own 58% of the company

November 7, 2022 | finance.yahoo.com

Apollo Endosurgery to Participate in Upcoming Investor Conferences

November 1, 2022 | finance.yahoo.com

Apollo Endosurgery, Inc. Reports Record $19.6 million Global Revenue in Third Quarter 2022

October 18, 2022 | finance.yahoo.com

Apollo Endosurgery to Report Third Quarter Results on November 1, 2022

October 12, 2022 | nasdaq.com

Investors in Apollo Endosurgery (NASDAQ:APEN) have made a favorable return of 92% over the past three years

October 10, 2022 | msn.com

Short Volatility Alert: Apollo Endosurgery, Inc.

See More Headlines

Receive APEN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Apollo Endosurgery and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings: 10/31/2021
Today: 4/19/2024
Fiscal Year End: 12/31/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Sector: Medical
Industry: Surgical & medical instruments
Sub-Industry: N/A
Current Symbol: NASDAQ:APEN
CUSIP: N/A
CIK: 1251769
Web: www.apolloendo.com
Phone: (512) 279-5100
Fax: 858-678-0900
Employees: 202
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): ($1.02)
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: $-39,840,000.00
Net Margins: -51.84%
Pretax Margin: -51.08%
Return on Equity: -89.48%
Return on Assets: -33.76%

Debt

Debt-to-Equity Ratio: 1.04
Current Ratio: 2.35
Quick Ratio: 1.89

Sales & Book Value

Annual Sales: $76.86 million
Price / Sales: 0.00
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: $0.69 per share
Price / Book: N/A

Miscellaneous

Outstanding Shares: 57,972,000
Free Float: 47,943,000
Market Cap: $579.72 million
Optionable: Not Optionable
Beta: 2.31

5G Stocks: The Path Forward is Profitable

Click the link below and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

Key Executives

Charles S. McKhann
President, Chief Executive Officer & Director
John Molesphini
Executive Vice President-Operations
Jeffrey G. Black
Chief Financial Officer, Secretary & Treasurer
Christopher J. Gostout
Chief Medical Officer
Tiffanie Gilbreth
Vice President-Clinical & Medical Affairs

Key Competitors

View All Competitors

APEN Stock Analysis - Frequently Asked Questions

How were Apollo Endosurgery's earnings last quarter?: Apollo Endosurgery, Inc. (NASDAQ:APEN) posted its quarterly earnings data on Sunday, October, 31st. The biotechnology company reported ($0.23) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.28) by $0.05. The biotechnology company had revenue of $16.35 million for the quarter, compared to the consensus estimate of $16.20 million. Apollo Endosurgery had a negative net margin of 51.84% and a negative trailing twelve-month return on equity of 89.48%. During the same period last year, the firm posted ($0.11) earnings per share.
What other stocks do shareholders of Apollo Endosurgery own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Apollo Endosurgery investors own include Obalon Therapeutics (OBLN), Novavax (NVAX), Inovio Pharmaceuticals (INO), Onconova Therapeutics (ONTX), OPKO Health (OPK), Pfizer (PFE), Sunesis Pharmaceuticals (SNSS), Biocept (BIOC), Co-Diagnostics (CODX) and Second Sight Medical Products (EYES).

This page (NASDAQ:APEN) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Apollo Endosurgery (APEN) Stock Price, News & Analysis

About Apollo Endosurgery Stock (NASDAQ:APEN)

APEN Stock News Headlines

Company Calendar

Industry, Sector and Symbol

Profitability

Debt

Sales & Book Value

Miscellaneous

Key Executives

Key Competitors

APEN Stock Analysis - Frequently Asked Questions

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info